Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna L Godfrey

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Blood Reviews|November 26, 2016
After 10years of JAK2V617F: Disease biology and current management strategies in polycythaemia veraJacob Grinfeld, Anna L Godfrey
Hematology/Oncology Clinics of North America|September 27, 2012
Genotype-phenotype interactions in the myeloproliferative neoplasmsAnna L Godfrey, Anthony R Green
Hemasphere|April 21, 2021
Low-Risk Essential Thrombocythemia: A Comprehensive ReviewAndrew J Robinson, Anna L Godfrey
Blood Reviews|June 24, 2020
Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practiceJoe Lee, Anna L Godfrey, Jyoti Nangalia
Blood|November 15, 2022
Essential thrombocythemia: challenges in clinical practice and future prospectsAnna L Godfrey, Anna C Green, Claire N Harrison
Haematologica|May 2, 2013
Clonal analyses reveal associations of JAK2V617F homozygosity with hematologic features, age and gender in polycythemia vera and essential thrombocythemiaAnna L Godfrey, Edwin Chen, Francesca Pagano, et al.
Nature Cancer|July 20, 2023
Clonal origin of KMT2A wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapyTim H H Coorens, Grace Collord, Taryn D Treger, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2026
Expanding the clinical tumor phenotype of the EPAS1-asssociated tumor syndromeYasemin Cole, Sophie Howarth, Asna Javaid, et al.
Cell Reports|December 22, 2015
RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic InstabilityEdwin Chen, Jong Sook Ahn, David B Sykes, et al.
Nature|January 21, 2022
Life histories of myeloproliferative neoplasms inferred from phylogeniesNicholas Williams, Joe Lee, Emily Mitchell, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Blood Reviews|November 26, 2016
After 10years of JAK2V617F: Disease biology and current management strategies in polycythaemia veraJacob Grinfeld, Anna L Godfrey
Hematology/Oncology Clinics of North America|September 27, 2012
Genotype-phenotype interactions in the myeloproliferative neoplasmsAnna L Godfrey, Anthony R Green
Hemasphere|April 21, 2021
Low-Risk Essential Thrombocythemia: A Comprehensive ReviewAndrew J Robinson, Anna L Godfrey
Blood Reviews|June 24, 2020
Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practiceJoe Lee, Anna L Godfrey, Jyoti Nangalia
Blood|November 15, 2022
Essential thrombocythemia: challenges in clinical practice and future prospectsAnna L Godfrey, Anna C Green, Claire N Harrison
Haematologica|May 2, 2013
Clonal analyses reveal associations of JAK2V617F homozygosity with hematologic features, age and gender in polycythemia vera and essential thrombocythemiaAnna L Godfrey, Edwin Chen, Francesca Pagano, et al.
Nature Cancer|July 20, 2023
Clonal origin of KMT2A wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapyTim H H Coorens, Grace Collord, Taryn D Treger, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2026
Expanding the clinical tumor phenotype of the EPAS1-asssociated tumor syndromeYasemin Cole, Sophie Howarth, Asna Javaid, et al.
Cell Reports|December 22, 2015
RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic InstabilityEdwin Chen, Jong Sook Ahn, David B Sykes, et al.
Nature|January 21, 2022
Life histories of myeloproliferative neoplasms inferred from phylogeniesNicholas Williams, Joe Lee, Emily Mitchell, et al.
Pageof 3